U.S. Moratorium(ish) on Gain-of-Function Research
Evaluating the effectiveness of the 2014 U.S. moratorium on gain-of-function experimentsIn the last two articles, we discussed the vindication of the lab leak theory through the publication of several investigative articles, and the risky nature of gain-of-function research and the evidence that it may be a key component to the cause of the COVID-19 pandemic. Now, we turn to the U.S. Due to the risky nature of gain-of-function research, what actions has the U.S. government taken to mitigate those risks? In 2014, the U.S. government placed a moratorium on new gain-of-function experiments for influenza, MERS, and SARS. That moratorium defines “gain-of-function” in very broad terms covering any “research that improves the ability of a pathogen to cause disease.” The moratorium expired in 2017 and was replaced by an oversight board, Read More ›